- Tetracaine
drugbox
IUPAC_name = 2-(dimethylamino)ethyl 4-(butylamino)benzoate
CAS_number = 94-24-6
CAS_supplemental = CAS|136-47-0 (hydrochloride )
ATC_prefix = C05
ATC_suffix = AD02
ATC_supplemental = ATC|D04|AB06 ATC|N01|BA03 ATC|S01|HA03
PubChem = 5411
DrugBank =
C = 15 | H = 24 | N = 2 | O = 2
molecular_weight = 264.363 g/mol
bioavailability =
protein_bound = 75.6
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status =
routes_of_administration = Topical, Epidural, SpinalTetracaine (INN, also known as amethocaine; trade name Pontocaine) is a potent
local anesthetic of theester group. It is mainly used topically, inophthalmology and as anantipruritic , and has been used inspinal anesthesia .In
biomedical research , tetracaine is used to alter the function of calcium release channels (ryanodine receptor ) that control the release of calcium from intracellular stores. Tetracaine is an allosteric blocker of channel function. At low concentrations, tetracaine causes an initial inhibition of spontaneous calcium release events, while at high concentrations, tetracaine blocks release completely [Györke, S., V. Lukyanenko, et al. Dual effects of tetracaine on spontaneous calcium release in rat ventricular myocytes. J Physiol 1997;500(Pt 2):297-309.] .References
1. Györke, S., V. Lukyanenko, et al. Dual effects of tetracaine on spontaneous calcium release in rat ventricular myocytes. J Physiol 1997;500(Pt 2):297-309.
Faisal Al-Otaibi
Wikimedia Foundation. 2010.